Samia Khoury

About Samia Khoury

Samia Khoury, With an exceptional h-index of 81 and a recent h-index of 42 (since 2020), a distinguished researcher at American University of Beirut, specializes in the field of Multiple sclerosis, EAE, Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries

Comparative effectiveness of natalizumab, fingolimod, and injectable therapies in pediatric-onset multiple sclerosis: A registry-based study

Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study

Psychometric validation of the Arabic multiple sclerosis resiliency scale: Uncovering resilience factors in Lebanese MS patients for clinical and research advancements

Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies

Disease activity during pre-conception, pregnancy and postpartum in women with MS receiving ocrelizumab or other disease-modifying therapies in a real-world cohort

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

Samia Khoury Information

University

Position

Professor of Neurology & visiting professor of Neurology Harvard Medical School

Citations(all)

29954

Citations(since 2020)

6963

Cited By

25413

hIndex(all)

81

hIndex(since 2020)

42

i10Index(all)

206

i10Index(since 2020)

132

Email

University Profile Page

Google Scholar

Samia Khoury Skills & Research Interests

Multiple sclerosis

EAE

Immunology

Top articles of Samia Khoury

Comparative effectiveness of natalizumab, fingolimod, and injectable therapies in pediatric-onset multiple sclerosis: A registry-based study

Neurology

2024/4/9

Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study

Journal of Neurology, Neurosurgery & Psychiatry

2024/4/3

Psychometric validation of the Arabic multiple sclerosis resiliency scale: Uncovering resilience factors in Lebanese MS patients for clinical and research advancements

eNeurologicalSci

2024/3/1

Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry

Journal of Neurology, Neurosurgery & Psychiatry

2024/1/19

Central vein sign and paramagnetic rim sign: From radiologically isolated syndrome to multiple sclerosis

2023/9

Health-related Quality of Life and Utilities among Lebanese Patients with Multiple Sclerosis: A cross-sectional study

Multiple Sclerosis and Related Disorders

2024/4/16

The societal costs of multiple sclerosis in Lebanon: a cross-sectional study

2023/4/21

External validation of a clinical prediction model in multiple sclerosis

Video-Assisted Thoracic Surgery

2022/12/30

Stat1 is an inducible transcriptional repressor of neural stem cells self-renewal program during neuroinflammation

Frontiers in Cellular Neuroscience

2023

Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network

Journal of Neurology, Neurosurgery & Psychiatry

2023/1/1

Clinical validation of a multi-protein, Serum-based assay for disease activity assessments in multiple sclerosis

Clinical Immunology

2023/8/1

safety and efficacy of disease modifying therapies after switching from natalizumab: a menactrims observational study

Multiple Sclerosis and Related Disorders

2023/12/1

Samia Khoury
Samia Khoury

H-Index: 40

Hani Dimassi
Hani Dimassi

H-Index: 23

See List of Professors in Samia Khoury University(American University of Beirut)